Showing results (441-450 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|January 16, 2015
Synthesis and Biological Evaluation of Pyrazolo[1,5-a]pyrimidine Compounds as Potent and Selective Pim-1 InhibitorsYong Xu, Benjamin G Brenning, Steven G Kultgen, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine KinasesJing Dong, Hongtao Zhao, Ting Zhou, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Recent progress in antitumoral synthetic vaccinesCristina Nativi, Olivier Renaudet
ACS Medicinal Chemistry Letters|November 20, 2014
Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl SubstituentsJames Adams, Edward C Anderson, Emma E Blackham, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Synthesis and biological evaluation of sophoridinol derivatives as a novel family of potential anticancer agentsChongwen Bi, Caixia Zhang, Yinghong Li, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Discovery of Highly Potent Dual CysLT1 and CysLT2 AntagonistSatoshi Itadani, Shinya Takahashi, Masaki Ima, et al.
ACS Medicinal Chemistry Letters|November 20, 2014
Synthesis, in Vitro Covalent Binding Evaluation, and Metabolism of (14)C-Labeled Inhibitors of 11β-HSD1Daqing Sun, Qiuping Ye, Xuelei Yan, et al.
ACS Medicinal Chemistry Letters|December 18, 2014
Synthesis and Characterization of a "Turn-On" photoCORM for Trackable CO Delivery to Biological TargetsSamantha J Carrington, Indranil Chakraborty, Jenna M L Bernard, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell LinesLuladey Ayalew, Jessica Acuna, Selina F Urfano, et al.
ACS Medicinal Chemistry Letters|August 25, 2017
Discovery of Potent EV71 Capsid Inhibitors for Treatment of HFMDPeng Li, Jun Yu, Fei Hao, et al.
Pageof 438